Masimo (MASI) Change in Receivables (2009 - 2026)
Masimo's (MASI) quarterly Change in Receivables came in at -$32.4 million in Q2 2026, down 1217.24% year-on-year from $2.9 million in Q2 2025, and down 58.82% quarter-over-quarter from -$20.4 million in Q1 2026.
Masimo (MASI) Change in Receivables (2009 - 2026) Analysis & Trends
Masimo's Change in Receivables history runs 18 years deep, the most recent figure standing at -$32.4 million for Q2 2026.
- On a quarterly basis, Change in Receivables fell 1217.24% year-over-year to -$32.4 million in Q2 2026; TTM through Apr 2026 was -$37.5 million, a 186.01% decrease from a year earlier, with the FY2026 full-year figure at -$2.2 million, down 103.98% from the prior year.
- Change in Receivables fell to -$32.4 million in Q2 2026 per MASI's latest filing, from -$20.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $77.4 million in Q4 2022 and bottomed at -$61.1 million in Q3 2023.
- The 5-year median for Change in Receivables is $9.5 million (2023), against an average of $9.0 million.
- Across the five-year window, Change in Receivables plunged 8600.0% in 2023 and soared 215.62% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $77.4 million in 2022, then sank by 60.72% to $30.4 million in 2023, then decreased by 27.63% to $22.0 million in 2024, then tumbled by 64.09% to $7.9 million in 2025, then sank by 510.13% to -$32.4 million in 2026.
- Per Business Quant, the three latest MASI Change in Receivables figures stand at -$32.4 million (Q2 2026), -$20.4 million (Q1 2026), and $7.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -32.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -32.40 Mn |
| Apr 4, 2026 | -32.40 Mn |
| Jan 3, 2026 | -20.40 Mn |
| Jan 3, 2026 | -20.40 Mn |
| Sep 27, 2025 | 7.90 Mn |
| Sep 27, 2025 | 7.90 Mn |
| Jun 28, 2025 | 7.40 Mn |
| Jun 28, 2025 | 7.40 Mn |
| Mar 29, 2025 | 2.90 Mn |
| Mar 29, 2025 | 2.90 Mn |
| Dec 28, 2024 | 22.00 Mn |
| Dec 28, 2024 | 22.00 Mn |
| Sep 28, 2024 | 25.10 Mn |
| Sep 28, 2024 | 25.10 Mn |
| Jun 29, 2024 | -6.40 Mn |
| Jun 29, 2024 | -6.40 Mn |
| Mar 30, 2024 | 14.60 Mn |
| Mar 30, 2024 | 14.60 Mn |
| Dec 30, 2023 | 30.40 Mn |
| Dec 30, 2023 | 30.40 Mn |